U.S. Markets closed

Could Mylan’s Biosimilar Portfolio Be a Long-Term Growth Driver?

Margaret Patrick

According to a Deloitte report, the biosimilars market is expected to grow to a market value of more than $445.0 billion by the end of 2019.